Navigation Links
'Trojan Horse' agent halts bone metastasis in mice

moted growth of blood vessels to feed the neophyte cancer, Rosenblum said

To find out, Rosenblum designed an experiment with VEGF121/rGel, an agent he and his colleagues began to develop several years ago. They created the drug by fusing the smallest of VEGF proteins (VEGF 121) to a genetically engineered toxin, gelonin, derived from a plant that grows wild in India, and used bacteria to produce the fusion protein. The agent is designed to enter new blood vessel cells in tumors through expressed VEGF receptors and, once inside, the "Trojan Horse" toxin destroys the cell, disrupting the ability of tumors to form blood vessels to supply the nutrients they need to grow. Animal studies previously conducted by the researchers have shown that the protein can selectively destroy blood vessels feeding human solid tumors.

In this study, investigators implanted human prostate cancer cells, which are highly metastatic to bone, directly into the leg bone marrow of experimental mice in order to simulate a bone metastasis. A week later, they treated the animals with five staggered doses of VEGF121/rGel delivered through intravenous injections.

Half of the treated mice did not develop any bone tumors, Rosenblum says. "There was no evidence of cancer growth," he says, adding, "We don't know why the treatment didn't work in the other half of the mice, but we may have started therapy too late."

Rosenblum and his research team then found that VEGF121/rGel dramatically reduced the number of osteoclast cells in the leg bones and further research demonstrated that pre-osteoclast like cells, known as monocytes, had been expressing a receptor, Flt-1, designed to latch on to the VEGF protein secreted by cancer cells.

When activated by maturation factors including VEGF, the pre-osteoclasts differentiated into mature osteoclasts and chew up bone tissue, providing the tumor new space to grow. The mature osteoclast cells themselves do not ex
'"/>

Source:University of Texas M. D. Anderson Cancer Center


Page: 1 2 3

Related biology news :

1. Killing brain tumors from within: A Trojan horse approach
2. New drug shows promise as powerful anticancer agent
3. To control germs, scientists deploy tiny agents provocateurs
4. Gadonanotubes greatly outperform existing MRI contrast agents
5. Tiny avalanche photodiodes target bioterrorism agents
6. Software agents could help unmask reality of disease clusters
7. Mouse study: New muscle-building agent beats all previous ones
8. Chemical warfare agent detection technology used to treat lung disease
9. Got inexpensive contrast agent? Milk plays new role in imaging
10. Failed experiment yields a biocontrol agent that doesnt trigger antibiotic resistance
11. Gallium: A new antibacterial agent?
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Trojan Horse agent halts bone metastasis mice

(Date:8/25/2014)... Scientists have known that toxic effects of substances ... both natural and human-made materials, can pass from ... shows that females with ancestral exposure to EDC ... According to a new study by researchers from ... State University, male and female rats are affected ...
(Date:8/25/2014)... 133 active fires in the North Slave Region of the ... 24 hours. Fire danger is moderate to high. Smoke ... Lake Complex of fires are in an area approximately 80 ... north of Fort Providence. Four crews will be working ... week. Mop-up continues many areas of complex,s fire perimeter. The ...
(Date:8/25/2014)... a lightning strike on August 12, 2014. Currently the ... There are close to 2,000 personnel working on this ... and a number of large ones. Most of the ... 100 acres. An inversion layer settled over the fire ... keeping fire activity moderate. As the inversion lifted in the ...
Breaking Biology News(10 mins):Exposure to toxins makes great granddaughters more susceptible to stress 2Happy Camper and July Fire Complexes in California 2
... Va.Though many policymakers have argued that environmental regulations ... a new study by George Mason University researcher ... production processes can not only offset the costs ... The study, which looked at more than ...
... branch of Munich (Germany) based Genomatix Software GmbH, announced ... to provide Genomatix software and data content to Pfizer ... Pfizer are designed to show how genes are regulated ... the software and data content to help understand the ...
... International,Inc. (OTC Bulletin Board: BKYI), a leader in ... issued the following,open letter to its shareholders discussing ... performance., Highlights:, -- Revenue growth from ... in our installed base of law enforcement customers, ...
Cached Biology News:Corporations can profit from being environmentally friendly 2BIO-key(R) Issues Open Letter to Shareholders 2BIO-key(R) Issues Open Letter to Shareholders 3BIO-key(R) Issues Open Letter to Shareholders 4BIO-key(R) Issues Open Letter to Shareholders 5
(Date:8/26/2014)... 26, 2014 Genedata, a leading ... and life science research, today announced the ... be held in Asia, Europe, and North America ... companies and leading research organizations will gather for ... case studies, and upcoming challenges in all areas ...
(Date:8/26/2014)... CITY, Calif. , Aug. 26, 2014 /PRNewswire/ ... development and commercialization of oncology diagnostic products, has ... as a 2015 Technology Pioneer . As ... is one of 24 companies across a wide ... prestigious accolade. Guardant360 ® , ...
(Date:8/26/2014)... Cary, NC (PRWEB) August 26, 2014 ... built-in GMP processes, implemented a new pricing structure with ... better comply with cGMP and 21 CFR Part 11 ... Good Manufacturing Practices any way we can” said Rick ... the number of available users allowed customers to have ...
(Date:8/26/2014)... 26, 2014 Historically, drug development ... list continues to grow – high attrition rate, ... and development, high regulatory hurdles and increasing ... become clear that the traditional business model of ... are now seeking to find better ways to ...
Breaking Biology Technology:Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3Guardant Health Named a 2015 Technology Pioneer by World Economic Forum 2Transitioning from Bench into Clinical Phase, new webinar hosted by Xtalks 2
... Verenium Corporation (Nasdaq: VRNM ), a ... today announced that it has entered into an agreement ... United States ("Ex-Im Bank") for two 18-month, secured revolving ... These new credit facilities will allow the Company ...
... 2011 PharmaVentures today announced the launch of ... Essential Deal Trends: Oncology 2011 . This new series ... and commercialising new drugs. The first report in the series ... active deal making therapeutic area in the pharmaceutical and biotechnology ...
... cell carcinomas are amongst the most frequent cancers in ... like many other human cancers, contain particular cancer cells, ... potential that sustain tumor growth. Little is known about ... High level of VEGF expression in skin cancer ...
Cached Biology Technology:Verenium Announces Up to $16 Million in New Secured Financings 2Verenium Announces Up to $16 Million in New Secured Financings 3Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends 2Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends 3New role for Vascular Endothelial Growth Factor in regulating skin cancer stem cells 2
...
...
... Formulation: 50mM Tris-HCl, pH 7.5, ... PMSF, 1mM benzamidine, 0.1% 2-mercaptoethanol ... (Protein Phosphatase 2A1) partially purified ... precipitation, QSepharose,amino-hexyl agarose, Superdex 200, ...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Biology Products: